CClinicalTrials.gg
CompletedNCT05009316POPQUESTUpdated Apr 10, 2024

Impact of Social Support and Coping Strategies on Post-Surgical Pain

An interventional study of Questionnaires in Social Support, Coping Behavior and Post-Surgical Pain, Chronic, sponsored by Université Catholique de Louvain. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-10.

Sponsored by Université Catholique de Louvain · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
368
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to evaluate the impact of social support and pain coping strategies in the development and evolution of post-surgical pain.

Read the detailed description

This is a longitudinal study. After giving their informed consent, patients will answer online questionnaires assessing pain and different psychosocial variables at these time points: before surgery, one to three days after surgery, and one, three, and six months after surgery.

The psychosocial variables evaluated are the following ones :

  • Depression,
  • Anxiety,
  • Stress,
  • Pain Coping Strategies,
  • Social Support,
  • Couple Support.
02

Conditions studied

  • Social Support
  • Coping Behavior
  • Post-Surgical Pain, Chronic

Keywords

  • Pain, Chronic
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 368 is above the median of 60 across 2,161 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Université Catholique de Louvain is the lead sponsor of 144 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged over 18 years of age.
  • Capacity to understand and voluntarily sign an informed consent form in French.

Exclusion criteria

Exclusion Criteria:

  • Insufficient French language skills.
  • History of psychotic disease.
  • History of neurodegenerative pathology.
  • History of neurological disease (e.g. stroke)
  • Pre-existing pain condition related to the reason for surgery
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
368 participants (actual)

Study arms

  • Experimental
    Questionnaires

    Patients will answer online surveys containing different questionnaires that will evaluate psychosocial variables as well as pain variables.

    Other: Questionnaires

Interventions

  • OtherQuestionnaires

    Online-based questionnaires

06

What researchers measure

Primary outcomes

  1. Intensity of acute post-surgical pain

    Questions from the Short Form of the Brief Pain Inventory (translated in French) will be used to assess the intensity of the pain on a numeric rating scale (from 0 to 10) during the three days following surgery.

    Time frame: Three days after surgery

  2. Development of Persistent post-surgical pain, 3 months

    Using the Short Form of the Brief Pain Inventory, pain will be assessed at three months to determine whether patients will have developed chronic pain.

    Time frame: 3 months after surgery

  3. Persistent post-surgical pain, 6 months

    Using the Short Form of the Brief Pain Inventory, pain intensity will be assessed at 6 months.

    Time frame: 6 months after surgery

  4. Pain interference

    Using the Short Form of the Brief Pain Inventory, pain interference on daily activities will be assessed at 6 months.

    Time frame: 6 months after surgery

07

Study locations

1 site
  • Institute of NeuroScience (IONS) - UCLouvain
    Brussels, 1200, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05009316
Lead sponsor
Université Catholique de Louvain
Collaborators
European Commission
Responsible party
Sponsor
First posted
Aug 17, 2021
Start date
Sep 20, 2021
Primary completion
Dec 20, 2023
Completion
Mar 21, 2024
Last update
Apr 10, 2024

Study contacts

André Mouraux, Ph.D
study chair · Université Catholique de Louvain

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion